Assessment of ocrelizumab impact on neurofilament levels in multiple sclerosis patients
Multiple sclerosis (MS) is a debilitating neurological disease characterized by inflammation, demyelination, and neurodegeneration in the central nervous system. Despite extensive research, the pathology of MS remains incompletely understood. Ocrelizumab (OCRE), a monoclonal antibody targeting CD20-...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Sciendo
2024-07-01
|
| Seri Bilgileri: | Romanian Journal of Laboratory Medicine |
| Konular: | |
| Online Erişim: | https://doi.org/10.2478/rrlm-2024-0019 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|